Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul 24;43(8):801-5.
doi: 10.1038/ng.871.

Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction

Affiliations
Comparative Study

Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction

Jessica Shea et al. Nat Genet. .

Abstract

Noncoding variants at human chromosome 9p21 near CDKN2A and CDKN2B are associated with type 2 diabetes, myocardial infarction, aneurysm, vertical cup disc ratio and at least five cancers. Here we compare approaches to more comprehensively assess genetic variation in the region. We carried out targeted sequencing at high coverage in 47 individuals and compared the results to pilot data from the 1000 Genomes Project. We imputed variants into type 2 diabetes and myocardial infarction cohorts directly from targeted sequencing, from a genotyped reference panel derived from sequencing and from 1000 Genomes Project low-coverage data. Polymorphisms with frequency >5% were captured well by all strategies. Imputation of intermediate-frequency polymorphisms required a higher density of tag SNPs in disease samples than is available on first-generation genome-wide association study (GWAS) arrays. Our association analyses identified more comprehensive sets of variants showing equivalent statistical association with type 2 diabetes or myocardial infarction, but did not identify stronger associations than the original GWAS signals.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Comparison of targeted sequencing to 1000G Pilot 1 Data
Variant calls were made in all six regions of T2D association in the 32 individuals who were sequenced as part of both this targeted, high coverage sequencing effort (total 47 CEU HapMap individuals) as well as 1000G Pilot 1 (total 60 CEU HapMap individuals).
Figure 2
Figure 2. Fraction of variation on chromosome 9p21 captured in T2D disease cohort by different imputation scenarios
MACH imputation quality estimates (a, c, e) and overall fraction of variation captured in T2D samples (b, d, f) for different imputation scenarios. (a, c, e) The MACH-estimated r2 for each SNP is plotted as a function of genomic position. SNPs not observed in the reference panel are assigned an r2 of zero. Recombination rate (estimated from HapMap) is plotted to reflect local LD structure. Gene annotations were taken from the University of California-Santa Cruz Genome Browser. (b, d, f) The fraction of variants captured in T2D samples is shown as a function of MAF and MACH-estimated r2. Imputation scenarios are: (a, b) Imputing from HapMap II (n=238 SNPs in 60 individuals) into the SNPs genotyped on the Affymetrix 500K array; (c, d) Imputing from 112 individuals genotyped at HapMap II sites and validated sequencing sites (total n=464 SNPs) into the SNPs genotyped on the Affymetrix 500K array; (e, f) Imputing from the same reference panel as c, d into SNPs genotyped on the Affymetrix 500K array plus additional tag SNPs genotyped in the T2D cohort (genotyped marker density in T2D samples ~1 SNP/1.5kb).
Figure 3
Figure 3. Comparison of imputation from a genotyped reference panel, directly from high coverage re-sequencing data, and directly from 1000G Pilot 1 data
(a) Variants present in the three reference panels and their overlap. The 67 variants present in the genotyped reference panel but not in the high coverage sequencing reference panel (denoted by asterisk) were called in high coverage sequencing as singletons and so were excluded from the sequencing reference panel. 40% of these variants are not singletons in the larger genotyped reference panel. (b) The fraction of sites within each reference panel captured with a MACH-estimated r2 of at least 0.8. (c) The overall fraction of known variants captured with a MACH-estimated r2 of at least 0.8 by imputation from each reference panel.
Figure 4
Figure 4. Association results for T2D and MI on chromosome 9p21
Regional plots showing association signal for (a) T2D and (b) MI. The signal for each SNP (represented as −log10 p-value) is plotted as a function of genomic position. The size of the diamond for each SNP represents the LD (measured as r2) between that SNP and the original GWAS SNP (rs10811661 for T2D and rs4977574 for MI). Recombination rate (estimated from HapMap) is plotted to reflect the local LD structure in the region. Gene annotations were taken from the University of California-Santa Cruz Genome Browser.

Comment in

References

    1. Saxena R, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–1336. - PubMed
    1. Scott LJ, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–1345. - PMC - PubMed
    1. Zeggini E, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–645. - PMC - PubMed
    1. Zeggini E, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–1341. - PMC - PubMed
    1. Helgadottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493. - PubMed

Publication types

MeSH terms